Retinal Degeneration Fund Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 2

Professionals

  • Investments
  • 24

  • Portfolio
  • 15

  • Exits
  • 7

Exits

Retinal Degeneration Fund General Information

Company Description

Founded in 2018, Retinal Degeneration Fund is a not-for-profit venture capital fund based in Raleigh, North Carolina. The firm prefers to make venture philanthropy investments in companies developing therapeutic technologies for inherited retinal diseases and macular degeneration.

Business Details

Website
www.retinaldegenerationfund.org
Year Founded
2018
Investor Status
Actively Seeking New Investments
Primary Investor Type
Not-For-Profit Venture Capital
Other Investor Types
Venture Capital
Corporate Office
  • 223 South West Street
  • Suite 900
  • Raleigh, NC 27603
  • United States

Retinal Degeneration Fund Investments (24)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Osanni Bio 23-Jun-2026 Early Stage VC Drug Discovery Startup
Salution Health 29-May-2026 Other Commercial Services Startup
Beacon Therapeutics 09-Jan-2026 Drug Discovery Clinical Trials - Phase 3
Agnos Therapeutics 01-Jan-2026 Drug Discovery Clinical Trials - General
Nacuity Pharmaceuticals 29-Dec-2025 Drug Discovery Clinical Trials - Phase 3
Perceive Pharma 18-Feb-2025 Drug Discovery Startup
Checkedup 01-Dec-2024 Other Healthcare Technology Systems Generating Revenue
NVasc 04-Nov-2024 Drug Discovery Startup
Mireca 29-Jan-2024 Grant Drug Discovery Pre-Clinical Trials
Amber (Biotechnology) 03-Aug-2023 Seed Round Biotechnology Generating Revenue
You’re viewing 10 of 24 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Retinal Degeneration Fund Exits (7)

Company Name Exit Date Exit Type Exit Size
Opus Genetics (acquired in 2024)) 22-Oct-2024 Merger/Acquisition
Vedere Bio II 31-Mar-2023
Stargazer Pharmaceuticals 30-Mar-2022
Checkedup 20-Dec-2021
Vedere Bio 01-Sep-2020
Nayan Therapeutics 31-Jul-2020 Out of Business
SalioGen Therapeutics Out of Business
To view Retinal Degeneration Fund’s complete exits history, request access »

Retinal Degeneration Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Retinal Degeneration Fund FAQs

  • What is Retinal Degeneration Fund?

    Founded in 2018, Retinal Degeneration Fund is a not-for-profit venture capital fund based in Raleigh, North Carolina.

  • When was Retinal Degeneration Fund founded?

    Retinal Degeneration Fund was founded in 2018.

  • Where is Retinal Degeneration Fund headquartered?

    Retinal Degeneration Fund is headquartered in Raleigh, NC.

  • What is Retinal Degeneration Fund's total asset value?

    Retinal Degeneration Fund has around in total assets under management.

  • How many investments has Retinal Degeneration Fund made?

    Retinal Degeneration Fund has made 24 investments.

  • What has Retinal Degeneration Fund invested in?

    Retinal Degeneration Fund has made numerous investments in companies like Osanni Bio, Salution Health, and Beacon Therapeutics within the Drug Discovery and Commercial Services industries.

  • What has Retinal Degeneration Fund invested in recently?

    Retinal Degeneration Fund's latest investment was on 23-Jun-2026 in Osanni Bio, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process